This is a double-blind, randomized controlled trial comparing WBV therapy with a placebo intervention and standard care. A total of 150 participants will be recruited and investigated from Prince Mutib Hospital. Participants will be randomly allocated to one of three groups: WBV therapy, placebo (non-vibrating platform), or control (standard care). The study duration will be 12 weeks, with assessments conducted at baseline, post-intervention (12 weeks), and at a 6-month follow-up.
Protocol Parameters Summary
* Session Frequency: 3 times per week. * Session Duration: 25 minutes per session. * Vibration Frequency: 30 Hz. * Amplitude: 1-2 mm. * Program Duration: 12 weeks.
Adults aged 60 years and older.
Diagnosed with mild cognitive impairment (Montreal Cognitive Assessment (MoCA) score of 18-25). One point is added if years of education are less than 12 years[2].
Able to stand independently or with minimal assistance.
No contraindications for WBV therapy or exercise.
Diagnosis of dementia.
Severe musculoskeletal or neurological disorders.
Implanted electronic medical devices (e.g., pacemaker).
Inability to comprehend study instructions.